OpenAI
October 15, 2026
ResearchProduct
Bringing GPT‑Rosalind to academic research labs
Introducing the Rosalind Academic Plan, offering eligible labs sponsored access to GPT‑Rosalind and tools for life sciences discovery.
Loading…
We’re introducing the Rosalind Academic Plan to help more academic scientists access GPT‑Rosalind, our dedicated life sciences model, which combines frontier reasoning with Rosalind workbench(opens in a new window) that enables specialized tool orchestration across medicinal chemistry, genomics, wet-lab assistance, and other scientific applications. Eligible labs can receive up to 30 Business Standard seats at no cost for up to 12 months, with access to GPT‑Rosalind subject to trusted-access approval.
Academic research creates knowledge that entire fields build on. Work that begins with a fundamental question about biology can eventually change how we diagnose disease, develop medicines, or grow food. But those advances depend on scientists having the resources to explore ideas, test them, and share what they learn.
Accelerating scientific discovery is central to OpenAI’s mission of ensuring that artificial general intelligence benefits all of humanity. With this plan, we’re investing in the scientists doing that foundational work—helping more labs combine their expertise and judgment with AI tools built for life sciences research.
Many of the advances we rely on today grew out of years of basic research.
The Human Genome Project helped launch modern genomics, transforming medicine, diagnostics, and biotechnology.
Curiosity-driven work on bacterial immune systems led to CRISPR-Cas9, which revolutionized genome editing and is now advancing research in cancer, inherited disease, agriculture, and biotechnology. Decades of university research on mRNA also laid the groundwork for COVID-19 vaccines and a new generation of vaccines and therapies.
Academic research has always laid the groundwork for advances in medicine and biotechnology. By helping more scientists combine their scientific expertise and judgment with the advanced specialized reasoning of GPT‑Rosalind, we hope to support discoveries whose benefits reach far beyond the lab.
OpenAI is committed to enabling academic researchers to pursue their scientific ambitions. Distinguished academic labs are already exploring how GPT‑Rosalind can support work ranging from protein design to understanding neurodegeneration. These examples show where researchers are applying the model within their scientific workflows.
1 of 3
“GPT‑Rosalind helped me gather drug physicochemical parameters faster. PubChem and NCBI tools helped me work across ten drugs while refining the distinction between predicted and experimentally measured values”
Zhao Lab, UCSF
“I use GPT models throughout my research, from exploring the literature to refining experiments and computational approaches. They help me iterate on ideas much faster and explore more possibilities than ever before. I feel more efficient as a researcher, with more room to explore and think creatively.”
Dr. Mathieu Bourdenx, Bourdenx Lab
“Rosalind will not only help us improve our current discovery and design tasks, but also apply them at larger scales than previously possible while still providing useful insights to biological researchers.”
Dr. Brian Hie, Stanford University and Arc Institute
Zhao Lab, UCSF
Dr. Mathieu Bourdenx, Bourdenx Lab
Dr. Brian Hie, Stanford University and Arc Institute
With the new Rosalind Academic Plan, academic researchers can bring GPT‑Rosalind and Rosalind Workbench to their lab with greater flexibility and harness frontier model intelligence for scientific research.
Eligible labs receive:
Up to 30 Business Standard seats at $0 per user per month for up to 12 months.
Access to all commercially available frontier OpenAI models, subject to plan usage limits.
Access to GPT‑Rosalind following trusted-access approval.
Research data shared through the Rosalind Academic Plan is not used to train our models by default.
GPT‑Rosalind is a specialized life sciences model designed to support deeper reasoning on complex biological questions. Through trusted access, approved researchers can use it to investigate sensitive scientific questions within safeguards designed for legitimate research.
Areas of research include:
Drug and protein design
Designing candidate drugs, therapeutic proteins, peptides, and enzymes, and optimizing their molecular interactions, selectivity, stability, and suitability for development.
Disease detection and monitoring
Identifying molecular signatures of disease and developing liquid biopsies and other minimally invasive diagnostics to detect disease earlier, monitor progression, and assess treatment response.
Vaccines and immune responses
Designing and evaluating antibodies and vaccines against emerging viral variants, investigating host–pathogen interactions, and studying the strength and durability of protective immune responses.
Genetic and RNA therapies
Developing approaches to correcting genetic defects and modulating gene expression, designing RNA therapeutics, and investigating how to deliver treatments safely and effectively to intended tissues.
Agriculture and animal health
Investigating crop resilience, plant disease, and animal health, and applying genetic, nutritional, and biological insights to improve food production and veterinary care.
Ecology and conservation
Studying biodiversity, adaptation, species interactions, and environmental exposures to understand ecosystem change and inform conservation, bioremediation, and responses to climate change.
Antimicrobial resistance
Studying how microorganisms resist antibiotics, antivirals, and antifungals, and developing new treatments for resistant infections, biofilms, and persistent disease.
01 / 07
Card 1 of 7: Drug and protein design
The Rosalind Academic Plan is currently available to academic labs at U.S. universities. PIs and lab leads at universities without an OpenAI Enterprise agreement can apply on behalf of their labs through our trusted access process. Labs at universities with an existing agreement must apply through their university’s Enterprise access process.
Once approved, PIs and lab leads can activate free access to GPT‑Rosalind for up to 30 named members, alongside the other OpenAI frontier models included in the plan. API access is not included at this time. Verified PIs and lab leads manage member permissions and are responsible for their lab’s approved use.
Choose the application path for your lab or organization.
Academic labs
Rosalind Academic Plan
For PIs and lab leads at eligible organizations without an existing Enterprise account.
Apply on behalf of your lab.
Apply for academic lab access(opens in a new window)
Existing Enterprise accounts
GPT-Rosalind access
For academic users at eligible institutions with an existing OpenAI Enterprise agreement.
Request access through your existing Enterprise account.
Request GPT-Rosalind access(opens in a new window)
GPT‑Rosalind access is subject to approval.
Learn more about eligibility, application requirements, and getting started in our help center guide(opens in a new window).
Before activating access, we:
Verify the institution’s legitimacy and the PI or lab lead’s identity
Review the lead’s professional background, institutional appointment, and authority to oversee lab access
Assess the lab’s institutional affiliation, research activities, and intended use
Establish clear responsibilities for the lab lead and a designated institutional safety contact
Safeguards continue after activation through monitoring and enforcement. For registered high-sensitivity use cases, our safety checks account for the approved research context. When questions arise, we may follow up with researchers to clarify the work and confirm authorization. This approach is designed to detect potential misuse while accounting for legitimate research context and reducing unnecessary interruptions to authorized work.
Specialized intelligence for complex scientific questions
We’re starting with academic labs as part of a broader effort to put useful AI tools in the hands of more scientists. By lowering the cost of access, we hope to give more researchers room to pursue ideas whose benefits could reach far beyond their own labs—from a clearer understanding of disease to better treatments and more resilient food systems.
Those advances will come from scientists asking important questions and doing the work to answer them. We want to help more of them do that work.
If you’re affiliated with an academic lab, learn more about the Rosalind Academic Plan and check whether you’re eligible(opens in a new window).
2026
Keep reading
View all
Helping teens learn, plan, and shape the future of AI
ProductOct 7, 2026
GPT-6 and Intelligent UI for everyone
ProductOct 7, 2026
Sharing AI progress in mathematics
ResearchOct 6, 2026